Cutaneous Sarcoidosis
Sarcoidosis with Generalized Specific Granulomatous Skin Lesions
This protocol addresses sarcoidosis presenting with cutaneous involvement — specifically, multiple or generalized specific granulomatous skin lesions. When skin disease is widespread or involves several sites, the management approach differs from localised cutaneous sarcoidosis.
Clinical Situation
Patients with cutaneous sarcoidosis who develop several or generalized specific granulomatous skin lesions represent a subset where local measures alone are often insufficient. When lesions do not respond to local therapy or when skin disease is more generalized, systemic pharmacotherapy becomes necessary.
Treatment Approach
For severe or refractory generalized cutaneous sarcoidosis, a targeted biological therapy directed against a specific inflammatory mediator has an established role in management.
The full regimen — including agent selection, sequencing, and monitoring — is available in the structured protocol.
References
- If lesions do not respond to local therapy or if skin disease is more generalized, some type of pharmacotherapy is required.
- For very severe cases, anti-TNF therapy, such as infliximab may have a role.
View source ↗